TAIPEI, July 13, 2022 /PRNewswire/ — Health2Sync, Asia’s leading digital chronic disease management platform, announced today that it is signing a Memorandum of Understanding (MOU) with AstraZeneca Taiwan to provide its first digital solution for chronic kidney disease (CKD) patients in Taiwan.
Health2Sync and AstraZeneca Taiwan to Kick off Digital Patient Management Programs for Chronic Kidney Diseases comes via ChinaTechNews.com.
The Trump Reversal the World Needs
Washington steps up pressure on European allies to harden China stance
Brexit and the Special Relationship
How China’s property crisis has unfolded, from Evergrande to Country Garden
Sichuan Xinjin Road Group Co., Ltd. Announcement on the Resignation of Certain Directors and Independent Directors of the Company
China proposes stock stabilisation fund to lift economic confidence
Saving Global OrderChinese bonds: clutching at bamboo shoots
Tencent Invests In Chinese Knowledge Sharing Start-Up Zaihang And FendaMalaysia to resume China-built Belt and Road rail project